Your browser doesn't support javascript.
Traditional Chinese medicine in COVID-19.
Lyu, Ming; Fan, Guanwei; Xiao, Guangxu; Wang, Taiyi; Xu, Dong; Gao, Jie; Ge, Shaoqin; Li, Qingling; Ma, Yuling; Zhang, Han; Wang, Jigang; Cui, Yuanlu; Zhang, Junhua; Zhu, Yan; Zhang, Boli.
  • Lyu M; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • Fan G; Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Xiao G; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
  • Wang T; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • Xu D; Oxford Chinese Medicine Research Centre, University of Oxford, Oxford OX1 3PT, UK.
  • Gao J; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • Ge S; College of Traditional Chinese Medicine, Hebei University, Baoding 071002, China.
  • Li Q; College of Traditional Chinese Medicine, Hebei University, Baoding 071002, China.
  • Ma Y; Institute of Basic Medicine and Cancer, the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Chinese Academy of Sciences, Hangzhou 310022, China.
  • Zhang H; Oxford Chinese Medicine Research Centre, University of Oxford, Oxford OX1 3PT, UK.
  • Wang J; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • Cui Y; Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Zhang J; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • Zhu Y; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • Zhang B; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Acta Pharm Sin B ; 11(11): 3337-3363, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1499623
ABSTRACT
COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across the globe, posing an enormous threat to public health and safety. Traditional Chinese medicine (TCM), in combination with Western medicine (WM), has made important and lasting contributions in the battle against COVID-19. In this review, updated clinical effects and potential mechanisms of TCM, presented in newly recognized three distinct phases of the disease, are summarized and discussed. By integrating the available clinical and preclinical evidence, the efficacies and underlying mechanisms of TCM on COVID-19, including the highly recommended three Chinese patent medicines and three Chinese medicine formulas, are described in a panorama. We hope that this comprehensive review not only provides a reference for health care professionals and the public to recognize the significant contributions of TCM for COVID-19, but also serves as an evidence-based in-depth summary and analysis to facilitate understanding the true scientific value of TCM.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Traditional medicine Language: English Journal: Acta Pharm Sin B Year: 2021 Document Type: Article Affiliation country: J.apsb.2021.09.008

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Traditional medicine Language: English Journal: Acta Pharm Sin B Year: 2021 Document Type: Article Affiliation country: J.apsb.2021.09.008